Back to All
Press Release

Qualcomm Provides £330,000 (US$500,000) to Establish Scholarships in Biomedical Engineering at University of Oxford

Funding Provides Means for Most Highly Rated MSc Graduates to Continue into Doctoral Studies

Qualcomm Incorporated (Nasdaq: QCOM), a leading developer of advanced wireless technologies and data solutions, today announced funding of £330,000 (US$500,000) to establish four scholarships aimed at supporting top Master of Science (MSc) graduates of the University of Oxford's Biomedical Engineering (BME) programme as they continue into their doctoral studies. The donation, which establishes the Qualcomm Scholarships in Biomedical Engineering at the Oxford Institute of Biomedical Engineering, reflects Qualcomm's commitment to fostering exceptional talent and extending innovation into new markets.

“Biomedical engineering is an emerging discipline promising exciting advancements in clinical and medical sciences that will ultimately enhance health care for us all,” said John Caterer, managing director of Qualcomm UK. “By establishing these scholarships in collaboration with the University of Oxford, Qualcomm is contributing very directly to the betterment of society.”

“Qualcomm's generous gift will not only enable four of the most highly rated graduates of our programme to continue their studies, but it also has the potential to make a major contribution to unmet clinical needs worldwide,” said Dr. J. Frederick Cornhill, founding director of the Oxford Institute of Biomedical Engineering.

The four scholarships will provide support for the students' entire doctoral programmes (usually 42 months) and will be awarded to the two most highly ranked students in the BME MSc programme by an internal academic committee at the University of Oxford. The first two scholarships will be awarded in June 2009, enabling students to begin their DPhil studies in October 2009. The second two scholarships will be awarded in June 2010 with studies beginning in October 2010.

“Oxford University is enormously grateful for the donation from Qualcomm,” said Dr. John Hood, vice-chancellor of Oxford University. “The University of Oxford has a long history of excellence in biomedical engineering and education and these new scholarships will help us in the core activity of training the next generation of biomedical engineers.”

Qualcomm Incorporated (Nasdaq: QCOM) is a leader in developing and delivering innovative digital wireless communications products and services based on CDMA and other advanced technologies. Headquartered in San Diego, Calif., Qualcomm is included in the S&P 100 Index, the S&P 500 Index and is a 2008 FORTUNE 500® company. For more information, please visit www.qualcomm.com.

###

Snapdragon and Qualcomm branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries.

Qualcomm, Qualcomm Dragonwing and Snapdragon are trademarks or registered trademarks of Qualcomm Incorporated.

Qualcomm is a registered trademark of Qualcomm Incorporated. All other trademarks are the property of their respective owners.

Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Our leading-edge AI, high performance, low-power computing, and unrivaled connectivity deliver proven solutions that transform major industries. At Qualcomm, we are engineering human progress.

Stay connected

Get the latest Qualcomm and industry information delivered to your inbox.

Subscribe
Manage your subscription

© Qualcomm Technologies, Inc. and/or its affiliated companies.

Snapdragon and Qualcomm branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries. Qualcomm patented technologies are licensed by Qualcomm Incorporated.

Note: Certain services and materials may require you to accept additional terms and conditions before accessing or using those items.

References to "Qualcomm" may mean Qualcomm Incorporated, or subsidiaries or business units within the Qualcomm corporate structure, as applicable.

Qualcomm Incorporated includes our licensing business, QTL, and the vast majority of our patent portfolio. Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of our engineering, research and development functions, and substantially all of our products and services businesses, including our QCT semiconductor business.

Materials that are as of a specific date, including but not limited to press releases, presentations, blog posts and webcasts, may have been superseded by subsequent events or disclosures.

Nothing in these materials is an offer to sell or license any of the services or materials referenced herein.